essential thrombocythemia: outcomes, unmet needs, and therapeutic strategies
Published 3 years ago • 4K plays • Length 8:07Download video MP4
Download video MP3
Similar videos
-
3:29
unmet needs and therapeutic strategies in essential thrombocythemia
-
3:59
pv: outcomes, unmet needs, and therapeutic strategies
-
3:06
the unmet needs of essential thrombocythemia and polycythemia vera patients
-
0:35
novel therapeutics in essential thrombocythemia
-
3:21
the current standard of care for patients with essential thrombocythemia
-
3:53
essential thrombocythemia watch & wait | what patients should know
-
13:08
essential thrombocythemia: what patients should know (2022) | top mpn specialist dr. ruben mesa
-
29:30
joseph scandura, md phd - managing essential thrombocythemia in 2023
-
7:58
essential thrombocytosis (et) | myeloproliferative neoplasm (jak2 kinase)
-
2:15
advances in the risk stratification and treatment of essential thrombocythemia
-
0:45
non-pharmaceutical interventions for patients with mpns and other hematological malignancies
-
1:03
most: an observational study of myelofibrosis and essential thrombocythemia
-
1:57
surpass et: p1101 in essential thrombocythemia
-
1:43
updates from a phase ii study of bomedemstat for the treatment of essential thrombocythemia
-
1:12
unmet needs in et and future considerations
-
1:25
exciting updates in essential thrombocythemia: exploring novel agents
-
9:36
what is essential thrombocythemia? | hematologic system diseases | nclex-rn | khan academy
-
1:05
unmet needs in gvhd & the promise of regenerative medicine
-
1:47
bomedemstat normalizes platelet count for essential thrombocythemia
-
13:59
essential thrombocythemia
-
1:13
the unmet needs and future of cmml treatment
-
1:05
hematological predictors of thrombotic risk or disease progression in essential thrombocythemia